List of insiders holdings for ALDER BIOPHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| H LUNDBECK A S 10% Owner | 2019-10-24 18:55:18 | 101,167,019 0 | 101,167,019 | Form 13D |
| Bridger Gary Director | 2015-11-03 17:59:06 | 0 3,469,528 | 3,469,528 | Form 4 |
| Delphi Management Partners VII L.L.C. DELPHI VENTURES VII L P DELPHI BIOINVESTMENTS VII LP PAKIANATHAN DEEPIKA ROEDER DOUGLAS A DOUGLASS DAVID L BOCHNOWSKI JAMES J 10% Owner | 2018-02-13 13:50:51 | 2,859,882 0 | 2,859,882 | Form 13G |
| Ventures West 8 Limited Partnership 10% Owner | 2016-02-16 13:50:27 | 2,532,767 0 | 2,532,767 | Form 13G |
| Novo A/S SEE REMARKS 10% Owner | 2015-07-02 11:03:08 | 1,951,183 0 | 1,951,183 | Form 13G |
| Davidson Aaron Director | 2014-05-15 17:14:46 | 0 516,395 | 516,395 | Form 4 |
| Latham John A Chief Scientific Officer | 2019-02-08 16:47:56 | 404,180 0 | 404,180 | Form 4 |
| DOW STEPHEN M Director | 2017-07-18 19:50:48 | 0 307,190 | 307,190 | Form 4 |
| JAGGERS JOHN V BAYLESS JON W DOMENIK STEPHEN L KIMZEY JACKIE R McLean David J. OXAAL JOHN T SCHUELE ALAN R STURIALE NICHOLAS G Affiliate | 2016-02-05 12:37:31 | 282,190 0 | 282,190 | Form 13G |
| Schatzman Randall C President and CEO | 2018-02-21 17:39:15 | 200,000 0 | 200,000 | Form 4 |
| Litton Mark James Chief Business Officer | 2018-06-05 17:40:18 | 102,189 78,000 | 180,189 | Form 4 |
| Redmile Group LLC Green Jeremy Director | 2019-10-24 19:17:21 | 0 170,243 | 170,243 | Form 4 |
| Whitaker Timothy M Chief Medical Officer | 2017-01-31 17:29:51 | 75,000 0 | 75,000 | Form 4 |
| Carter Eric G Interim Chief Medical Officer | 2018-04-25 17:27:08 | 75,000 0 | 75,000 | Form 4 |
| Sandoval Elisabeth CCO & EVP, Corporate Strategy | 2018-02-21 17:42:49 | 60,000 0 | 60,000 | Form 4 |
| Benedict Larry EVP and PAO | 2019-04-25 18:53:24 | 39,728 0 | 39,728 | Form 4 |
| PAKIANATHAN DEEPIKA Director | 2018-05-25 17:16:25 | 15,000 0 | 15,000 | Form 4 |
| SRB Associates IX L.P. Sevin Rosen Fund IX L.P. Sevin Rosen IX Affiliates Fund L.P. Affiliate | 2015-09-02 14:51:59 | 88 0 | 88 | Form 4 |
| Preston Heather Director | 2019-10-24 19:01:53 | 0 0 | 0 | Form 4 |
| SIEGALL CLAY B Director | 2019-10-24 19:03:25 | 0 0 | 0 | Form 4 |
| Lavelle Erin Chief Operating Officer | 2019-10-24 19:12:48 | 0 0 | 0 | Form 4 |
| Montgomery Alan Bruce Director | 2019-10-24 18:58:45 | 0 0 | 0 | Form 4 |
| YARNO WENDY L Director | 2019-10-24 19:05:36 | 0 0 | 0 | Form 4 |
| Smith Jeffrey T L Managing Director Director | 2019-10-24 19:07:40 | 0 0 | 0 | Form 4 |
| Hassler Randal EVP, Pharmaceutical Ops. | 2019-10-24 19:09:15 | 0 0 | 0 | Form 4 |
| Bucher James B EVP & General Counsel | 2019-10-24 19:10:50 | 0 0 | 0 | Form 4 |
| Bisgaard Peter Director | 2014-05-07 20:01:29 | 0 0 | 0 | Form 3 |
| Cleveland Paul B Director | 2019-10-24 18:56:38 | 0 0 | 0 | Form 4 |
| Carter Paul Rutherford Director | 2019-10-24 18:55:08 | 0 0 | 0 | Form 4 |
| Azelby Robert President and CEO | 2019-10-24 18:52:57 | 0 0 | 0 | Form 4 |
| Campoy Carlos Chief Financial Officer | 2019-10-24 19:30:30 | 0 0 | 0 | Form 4 |
| STRECK PAUL Chief Medical Officer | 2019-10-24 19:28:07 | 0 0 | 0 | Form 4 |
| Dac Nadia Chief Commercial Officer | 2019-10-24 19:26:23 | 0 0 | 0 | Form 4 |
| H.I.G. Venture Partners II L.P. H.I.G. Ventures - Alder LLC 10% Owner | 2016-02-12 11:59:05 | 0 0 | 0 | Form 13G |
| TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G 10% Owner | 2020-02-13 16:18:09 | 0 0 | 0 | Form 13G |